Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

ASC-60 is under clinical development by Sagimet Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate ...

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...

New Hampshire was the state with the highest level of respiratory illness activity, according to the CDC. Americans can prevent the spread of viruses in several ways, such as staying home when they ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the symptoms to look for.

Flu, Respiratory Syncytial Virus (RSV) and COVID-19 cases are on the rise in East Texas mostly impacting children. The Texas ...

Typically, flu activity starts to pick up around Halloween and peaks in February. This year, however, the virus got off to a ...

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

The UK Health Security Agency (UKHSA) has updated its advice on the symptoms of Covid to watch out for, as variants of the ...